Latest News

Funding for project looking to link datasets June 27, 2017

Government support for a project aiming to integrate key Australian health datasets, including the PBS and MBS, through the latest round of grants under the Cooperative Research Centre Projects initiative.

‘Tsunami of change’ coming June 27, 2017

A ‘tsunami of change’ is coming to the conduct of clinical trials according to Dr Rob Scott, chief medical officer and global head of development at AbbVie.

CSIRO marks one year of Data61 operations June 27, 2017

Data61 was formed to help ensure Australia is positioned to take advantage of what is commonly described as the world's fourth industrial revolution - the convergence of IT, biology and materials science.

Crunch time on working visa changes June 22, 2017

Crunch time is approaching for the life sciences sector on the Turnbull government's changes to the working visa program.

Industry feedback requested on e-form and managing variations in registered medicines June 22, 2017

The TGA is working to implement an electronic application form for prescription medicines and a notification process for very low-risk changes to registered medicines, and is seeking feedback from industry stakeholders.

Imagion Biosystems lists on ASX June 22, 2017

Imagion Biosystems (ASX:IBX) has listed on the Australian Securities Exchange after completing a $12 million initial public offering (IPO).

Sienna seeks ASX listing with IPO June 22, 2017

Sienna Cancer Diagnostics has applied for listing on the Australian Stock Exchange.

Milestone payment for Regeneus June 22, 2017

Regeneus (ASX:RGS) will receive a milestone payment of US$1 million from AGC for meeting the primary endpoints of its Phase 1 safety trial of Progenza in patients with knee osteoarthritis.

MTPConnect: Clinical trials add $1.1bn to economy June 22, 2017

MTPConnect has released a new report, ‘Clinical Trials in Australia: the economic profile and competitive position of the sector’, it describes as the first comprehensive overview of the entire clinical trials landscape in Australia.

Recce secures funding for development of synthetic antibiotic June 20, 2017

Antibiotic maker Recce (ASX:RCE) has secured up to $6.05 million in an agreement with a US institutional investor.

Ethics approval for new Medlab trials June 20, 2017

Medlab Clinical (ASX: MDC) has received Human Research Ethics Committee (HREC) approvals to begin human trials of two different cannabis based medicines.

Parkinson's dataset reveals variation across markets June 20, 2017

Global Kinetics Corporation, a leader in digital health technology for people with Parkinson’s disease, has developed a dataset of more than 10,000 reports of symptoms from patients with PD.

Most Read

‘Tsunami of change’ coming

CSIRO marks one year of Data61 operations

Australia set to be targeted in Trump global drug review

Funding for project looking to link datasets

Governor of Victoria Export Awards now open

New Stories

Funding for project looking to link datasets

‘Tsunami of change’ coming

Governor of Victoria Export Awards now open

CSIRO marks one year of Data61 operations

Australia set to be targeted in Trump global drug review

Crunch time on working visa changes

Industry feedback requested on e-form and managing variations in registered medicines

Sign In

Most Read

‘Tsunami of change’ coming

CSIRO marks one year of Data61 operations

Australia set to be targeted in Trump global drug review

Funding for project looking to link datasets

Governor of Victoria Export Awards now open

Follow Us

New Stories

Funding for project looking to link datasets

‘Tsunami of change’ coming

Governor of Victoria Export Awards now open

CSIRO marks one year of Data61 operations

Australia set to be targeted in Trump global drug review

Crunch time on working visa changes

Industry feedback requested on e-form and managing variations in registered medicines